Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04856371
What this trial is testing

Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Haihe Biopharma Co., Ltd. 228
Not applicableStudy completedNCT05404334
What this trial is testing

Of Androgen Receptor Expression in Breast Cancer With or Without BRCA Mutation

Who this might be right for
Breast Cancer
Banaras Hindu University 231
Not applicableStudy completedNCT00121134
What this trial is testing

Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Harold J. Burstein, MD, PhD 164
Testing effectiveness (Phase 2)Looking for participantsNCT06840821
What this trial is testing

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

Who this might be right for
Advanced Solid Tumors
Mainline Biosciences (Shanghai) Co., Ltd 156
Testing effectiveness (Phase 2)UnknownNCT04580784
What this trial is testing

Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer

Who this might be right for
Breast CancerRadiotherapy Side Effect
Mona Salem 20
Testing effectiveness (Phase 2)Study completedNCT05444998
What this trial is testing

Neoadjuvant Inetetamab and Pyrotinib and Nab-paclitaxel for HER2+Breast Cancer

Who this might be right for
Breast Cancer
Xijing Hospital 20
Post-approval studies (Phase 4)Ended earlyNCT06162663
What this trial is testing

Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

Who this might be right for
Breast CancerInsomnia
Medical University of South Carolina 6
Not applicableLooking for participantsNCT07429487
What this trial is testing

Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

Who this might be right for
Breast CancerColorectal CancerOvarian Adenocarcinoma+2 more
Centre Antoine Lacassagne 98
Testing effectiveness (Phase 2)Study completedNCT00445406
What this trial is testing

Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Swiss Cancer Institute 43
Not applicableEnded earlyNCT02393833
What this trial is testing

IBCSG Trial 22-00 Serum Substudy

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 136
Large-scale testing (Phase 3)Study completedNCT02574455
What this trial is testing

Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Gilead Sciences 529
Not applicableUnknownNCT05654571
What this trial is testing

Weight Loss and Breast Cancer

Who this might be right for
Breast CancerObesity, Morbid
Fatih Sultan Mehmet Training and Research Hospital 300
Not applicableActive Not RecruitingNCT05594498
What this trial is testing

StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients

Who this might be right for
Breast CancerRadiation Dermatitis
Sunnybrook Health Sciences Centre 45
Early research (Phase 1)Study completedNCT03667716
What this trial is testing

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Who this might be right for
Advanced CancerOvarian CancerBreast Cancer+7 more
Compugen Ltd 121
Testing effectiveness (Phase 2)Looking for participantsNCT04641247
What this trial is testing

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Who this might be right for
Ovarian NeoplasmsBreast Neoplasms
GlaxoSmithKline 37
Not applicableActive Not RecruitingNCT06059300
What this trial is testing

Digital Breast Tomosynthesis for the Dutch National Breast Cancer Screening Program

Who this might be right for
Breast Cancer Screening
Radboud University Medical Center 18,200
Testing effectiveness (Phase 2)Ended earlyNCT02685111
What this trial is testing

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Who this might be right for
Breast CancerNeutropeniaFebrile Neutropenia
Asan Medical Center 22
Not applicableActive Not RecruitingNCT07447544
What this trial is testing

Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS)

Who this might be right for
Breast CancerCentral Nervous System Metastases
Institute of Oncology Ljubljana 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07113964
What this trial is testing

QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)

Who this might be right for
Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency
The First Affiliated Hospital with Nanjing Medical University 79
Testing effectiveness (Phase 2)Study completedNCT00291798
What this trial is testing

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

Who this might be right for
Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 98
Next Page